DCGI approves anti-COVID drug developed by DRDO for emergency use
New Delhi, An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development …
DCGI approves anti-COVID drug developed by DRDO for emergency use Read More
